Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Surge Holdings Inc (SURG)

Surge Holdings Inc (SURG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Surge Holdings Inc

F: 636-939-6885

Description:

Synergetics USA, Inc. is a Delaware corporation incorporated on June 2, 2005 in connection with the reverse merger of Synergetics, Inc. ('Synergetics') and Valley Forge Scientific Corp. ('Valley Forge'). Synergetics was founded in 1991. The Company is a supplier of precision surgical devices. The Company's main focus is on the disciplines of ophthalmology and neurosurgery. Its distribution channels include a combination of direct and independent distributor sales organizations and important strategic alliances with market leaders. The Company's product lines focus upon precision engineered, disposable and reusable devices, procedural kits and the delivery of various energy modalities for the performance of surgery, including: laser energy, ultrasonic energy, radio frequency energy for electrosurgery and lesion generation and visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. It's ophthalmic and vitreoretinal surgical devices and equipment compete against manufacturers of similar products, including those sold by its major competitors, Alcon, Bausch & Lomb, Inc., Dutch Ophthalmic Research Center and Iridex. The Company is subject to macro-economic fluctuations in the United States, the countries of Europe and the economies of other countries throughout the world. Medical device companies are subject to rigorous regulation, including by the FDA and numerous other federal, state and foreign governmental authorities.

Key Statistics

Overview:

Annual Sales, $ 64,770 K
Annual Net Income, $ 3,060 K

Growth:

1-Year Return -45.19%
3-Year Return 55.78%
5-Year Return -22.50%

Per-Share Information:

Next Earnings Date 10/20/15
EPS Growth vs. Prev Qtr -28.57%
EPS Growth vs. Prev Year 25.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%

SURG Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward 1.42
Price/Earnings to Growth 1.72
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % N/A
Net Margin % 8.66
Debt/Equity 0.03
Price/Sales 2.27
Price/Cash Flow N/A
Price/Book 2.50
Book Value/Share 2.67
Interest Coverage 68.07
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar